Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma-a prospective multicenter observational study pointing out new unmet needs

Pim J J Damen, Joost J C Verhoeff

Research output: Contribution to journalEditorialAcademicpeer-review

6 Downloads (Pure)
Original languageEnglish
Pages (from-to)688-691
Number of pages4
JournalTranslational Cancer Research
Volume12
Issue number3
DOIs
Publication statusPublished - 31 Mar 2023

Keywords

  • Checkpoint inhibitors
  • Response Evaluation Criteria in Solid Tumors (RECIST)
  • abscopal response
  • oligoprogression
  • radiotherapy

Cite this